Literature DB >> 9521186

Agreement among indicators of vitamin C status.

C M Loria1, P K Whelton, L E Caulfield, M Szklo, M J Klag.   

Abstract

Agreement among three indicators of vitamin C status--serum ascorbate level, a 24-hour recall, and the frequency of fruit and vegetable consumption--was examined using data from the Second National Health and Nutrition Examination Survey conducted between 1976 and 1980. Agreement between pairs of these indicators was good when assessed at the group level but inconsistent at the individual level. These indicators, when classified as continuous measures, had moderately good agreement (r = 0.45-0.54), whereas agreement was poor when classified as quartiles (kappa = 0.17-0.23). Agreement between clinically based categories of serum ascorbate and total intake levels was poorer than expected (kappa = 0.25) as was agreement between low or deficient levels of both of these indicators (kappa = 0.3). Disagreement between low or deficient serum and intake levels was greater in participants who were younger, African American compared with white and other races, less educated, current smokers, nonsupplement users, and examined in the winter compared with in the summer or fall. These findings suggest that the indicators cannot be used interchangeably to assess vitamin C status because they distinguish between different aspects of status, intake level versus serum level, an indicator of available pool. Moreover, depending upon how these indicators are used in statistical analyses, they may classify individuals differently.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521186     DOI: 10.1093/oxfordjournals.aje.a009491

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  9 in total

1.  Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994.

Authors:  Jeffrey S Hampl; Christopher A Taylor; Carol S Johnston
Journal:  Am J Public Health       Date:  2004-05       Impact factor: 9.308

2.  Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's esophagus.

Authors:  A Fountoulakis; I G Martin; K L M White; M F Dixon; J E Cade; H M Sue-Ling; C P Wild
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

3.  Prediagnostic plasma vitamin C and risk of gastric adenocarcinoma and esophageal squamous cell carcinoma in a Chinese population.

Authors:  Tram Kim Lam; Neal D Freedman; Jin-Hu Fan; You-Lin Qiao; Sanford M Dawsey; Philip R Taylor; Christian C Abnet
Journal:  Am J Clin Nutr       Date:  2013-09-11       Impact factor: 7.045

4.  Serum antioxidant status and mortality from influenza and pneumonia in US adults.

Authors:  Habyeong Kang; Howard Hu; Sung Kyun Park
Journal:  Public Health Nutr       Date:  2022-01-10       Impact factor: 4.539

5.  Antioxidants from diet or supplements do not alter inflammatory markers in adults with cardiovascular disease risk. A pilot randomized controlled trial.

Authors:  Antonella Dewell; Philip Tsao; Joseph Rigdon; Christopher D Gardner
Journal:  Nutr Res       Date:  2017-11-02       Impact factor: 3.315

6.  Association of plasma vitamin C concentration to total and cause-specific mortality: a 16-year prospective study in China.

Authors:  Shao-Ming Wang; Jin-Hu Fan; Philip R Taylor; Tram Kim Lam; Sanford M Dawsey; You-Lin Qiao; Christian C Abnet
Journal:  J Epidemiol Community Health       Date:  2018-08-12       Impact factor: 3.710

Review 7.  Factors Affecting Vitamin C Status and Prevalence of Deficiency: A Global Health Perspective.

Authors:  Anitra C Carr; Sam Rowe
Journal:  Nutrients       Date:  2020-07-01       Impact factor: 5.717

Review 8.  Is plasma vitamin C an appropriate biomarker of vitamin C intake? A systematic review and meta-analysis.

Authors:  Mahshid Dehghan; Noori Akhtar-Danesh; Catherine R McMillan; Lehana Thabane
Journal:  Nutr J       Date:  2007-11-13       Impact factor: 3.271

Review 9.  Correlation of D-xylose with severity and morbidity-related factors of COVID-19 and possible therapeutic use of D-xylose and antibiotics for COVID-19.

Authors:  Antony Cheudjeu
Journal:  Life Sci       Date:  2020-08-23       Impact factor: 5.037

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.